Kenya's National Tuberculosis Programme: Burden, Diagnosis and Treatment Access
Tuberculosis remains one of the leading causes of death from a single infectious agent in Kenya, but two decades of investment in the National Leprosy, Tuberculosis and Lung Disease Programme have substantially reduced incidence, mortality and undiagnosed cases.
NASCOP and the Kenya HIV Programme: From PEPFAR to U=U, Treatment Coverage, Prevention Innovations and the Path to Epidemic Control
Kenya hosts 1.4 million people living with HIV. A complete guide to the NASCOP-led HIV programme, PEPFAR support, treatment coverage, prevention innovations and the path to control.
Malaria Control in Kenya: Disease Burden, the National Malaria Strategy, the Insecticide-Treated Net Programme and the Path to Elimination
Malaria causes 3.5 million Kenyan cases annually with 10,700 deaths. A complete guide to disease burden, the National Malaria Strategy, ITNs, treatment and the elimination agenda.
Public Health Emergencies in Kenya: Disease Outbreaks, Epidemic Preparedness, and Lessons from COVID-19
Public health emergencies, from endemic diseases like malaria to explosive outbreaks of cholera and the unprecedented challenge of COVID-19, have repeatedly tested Kenya's healthcare system and emerge...